AMANDA JENNINGS: Open Payments
NPI 1679194948 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 30 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $113 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $181 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $70 |
| Hydrofera LLC | 2 | $53 |
| Myriad Genetic Laboratories, Inc. | 2 | $52 |
| ABBVIE INC. | 2 | $33 |
| Integra LifeSciences Corporation | 1 | $25 |
| Smith+Nephew, Inc. | 1 | $19 |
| TELA Bio, Inc. | 1 | $17 |
| Solventum Corporation | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
Products named: GATTEX, JOURNAVX, HYDROFERA BLUE, MYRISK, DALVANCE, Integra, COLLAGENASE SANTYL, OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex).
Industry payments across LA — which companies pay providers there.
